Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20038030HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20048589HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20026706HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20048288HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20033039HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20021233HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS20032030HPVENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44018639HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44021744HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TVIS44029331HTLV-1ENSG00000133019.12protein_codingCHRM3NoNo1131P20309
TCGA Plot Options
Drug Information
GeneCHRM3
DrugBank IDDB03128
Drug NameAcetylcholine
Target IDBE0000045
UniProt IDP20309
Regulation Type
PubMed IDs10101037
CitationsBirdsall NJ, Farries T, Gharagozloo P, Kobayashi S, Lazareno S, Sugimoto M: Subtype-selective positive cooperative interactions between brucine analogs and acetylcholine at muscarinic receptors: functional studies. Mol Pharmacol. 1999 Apr;55(4):778-86.
GroupsApproved; Investigational
Direct ClassificationAcyl cholines
SMILESCC(=O)OCC[N+](C)(C)C
PathwaysFamotidine Action Pathway; Nizatidine Action Pathway; Esomeprazole Action Pathway; Pantoprazole Action Pathway; Ranitidine Action Pathway; Gastric Acid Production; Pirenzepine Action Pathway; Omeprazole Action Pathway; Lafutidine H2-Antihistamine Action; Rabeprazole Action Pathway; Phospholipid Biosynthesis; Betazole Action Pathway; Metiamide Action Pathway; Cimetidine Action Pathway; Roxatidine Acetate Action Pathway; Lansoprazole Action Pathway
PharmGKBPA448031
ChEMBLCHEMBL667